Literature DB >> 17261751

Endothelial function varies according to insulin resistance disease type.

Joshua A Beckman1, Allison B Goldfine, Andrea Dunaif, Marie Gerhard-Herman, Mark A Creager.   

Abstract

OBJECTIVE: We examined the relationship between insulin resistance and vascular function in three insulin-resistant states (type 2 diabetes, non-HIV lipodystrophic diabetes, and nondiabetic polycystic ovary syndrome [PCOS]) and in healthy control subjects. RESEARCH DESIGN AND METHODS: The population included 12 women with type 2 diabetes, 6 with lipodystrophic diabetes, 10 with PCOS, and 19 healthy female subjects. Metabolic measures included insulin sensitivity by the homeostasis model assessment, lipids, free fatty acids, and adiponectin. High-resolution B-mode ultrasound was used to determine endothelium-dependent and -independent vasodilation.
RESULTS: Type 2 diabetic, liposdystrophic, and PCOS subjects were insulin resistant compared with control subjects (P = 0.001). Flow-mediated vasodilation was reduced in diabetic (3.4 +/- 1.3%) compared with control (7.3 +/- 1.1%) subjects but not in lipodystrophic (7.7 +/- 1.2%) or PCOS (9.9 +/- 0.7%) subjects (P = 0.005). Nitroglycerin-mediated vasodilation was attenuated in both diabetic (15.2 +/- 2.0%) and lipodystrophic (16.7 +/- 3.6%) subjects compared with healthy control (24.6 +/- 2.4%) and PCOS (23.2 +/- 1.8%) subjects (P = 0.019). Insulin resistance, free fatty acids, adiponectin, or C-reactive protein did not associate with vascular dysfunction.
CONCLUSIONS: Among these different types of patients with insulin resistance, we found abnormal endothelium-dependent vasodilation only in the patients with type 2 diabetes. We postulate that variations in the mechanism of insulin resistance may affect endothelial function differently than glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261751     DOI: 10.2337/dc06-2142

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  12 in total

1.  Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 diabetes mellitus.

Authors:  Jessica Milian; Allison B Goldfine; Jonah P Zuflacht; Caitlin Parmer; Joshua A Beckman
Journal:  Acta Diabetol       Date:  2015-01-08       Impact factor: 4.280

2.  Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis.

Authors:  Shan Li; Xiamei Huang; Huizhi Zhong; Qiliu Peng; Siyuan Chen; Yantong Xie; Xue Qin; Aiping Qin
Journal:  Tumour Biol       Date:  2014-01-12

Review 3.  Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.

Authors:  Héctor F Escobar-Morreale; Manuel Luque-Ramírez; Frank González
Journal:  Fertil Steril       Date:  2010-12-17       Impact factor: 7.329

4.  Vascular effects of intravenous intralipid and dextrose infusions in obese subjects.

Authors:  Aidar R Gosmanov; Dawn D Smiley; Limin Peng; Joselita Siquiera; Gonzalo Robalino; Christopher Newton; Guillermo E Umpierrez
Journal:  Metabolism       Date:  2012-04-05       Impact factor: 8.694

5.  Interleukin-17A is associated with flow-mediated dilation and interleukin-4 with carotid plaque in persons with HIV.

Authors:  Celestine N Wanjalla; Tecla M Temu; Mona Mashayekhi; Christian M Warren; Bryan E Shepherd; Rama Gangula; Hubaida Fuseini; Samuel Bailin; Curtis L Gabriel; Pandu Gangula; Meena S Madhur; Spyros Kalams; Simon A Mallal; David G Harrison; Joshua A Beckman; John R Koethe
Journal:  AIDS       Date:  2022-02-14       Impact factor: 4.632

Review 6.  Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle.

Authors:  Michael G Clark
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-08       Impact factor: 4.310

Review 7.  Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.

Authors:  Krystallenia I Alexandraki; Eleni A Kandaraki; Kalliopi-Anna Poulia; Christina Piperi; Eirini Papadimitriou; Theodoros G Papaioannou
Journal:  touchREV Endocrinol       Date:  2021-04-28

8.  Evaluation of early atherosclerotic findings in women with polycystic ovary syndrome.

Authors:  Afshin Mohammadi; Mohammadreza Aghasi; Leila Jodeiry-Farshbaf; Shaker Salary-Lac; Mohammad Ghasemi-Rad
Journal:  J Ovarian Res       Date:  2011-10-24       Impact factor: 4.234

9.  Androgen deprivation therapy reversibly increases endothelium-dependent vasodilation in men with prostate cancer.

Authors:  Paul L Nguyen; Petr Jarolim; Shehzad Basaria; Jonah P Zuflacht; Jessica Milian; Samoneh Kadivar; Powell L Graham; Andrew Hyatt; Philip W Kantoff; Joshua A Beckman
Journal:  J Am Heart Assoc       Date:  2015-04-20       Impact factor: 5.501

10.  Anticytomegalovirus CD4+ T Cells Are Associated With Subclinical Atherosclerosis in Persons With HIV.

Authors:  Celestine N Wanjalla; Mona Mashayekhi; Samuel Bailin; Curtis L Gabriel; Leslie M Meenderink; Tecla Temu; Daniella T Fuller; Liang Guo; Kenji Kawai; Renu Virmani; Cathy Jenkins; Chike O Abana; Christian M Warren; Rama Gangula; Rita Smith; Meena S Madhur; Aloke V Finn; Alexander H Gelbard; Yan Ru Su; Matthew J Tyska; Spyros A Kalams; David G Harrison; Simon A Mallal; Tarek S Absi; Joshua A Beckman; John R Koethe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-02-11       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.